Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

'Roche Explores Selling Lung Disease Drug Amid Buyer Interest' - Bloomberg News

Author: Benzinga Newsdesk | February 26, 2024 12:40pm

https://www.bloomberg.com/news/articles/2024-02-26/roche-explores-selling-lung-disease-drug-amid-buyer-interest

Roche Holding AG is considering selling Esbriet, a lung disease drug that's seen sales plummet amid competition from cheaper generics.

The Swiss pharmaceuticals giant is in the early stages of evaluating a disposal after getting inbound interest from potential suitors, people with knowledge of the matter said, asking not to be identified

Posted In: RHHBY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist